Trial NCT00367497

View at ClinicalTrials.gov 
Org. Study IDs: 17-40

Last trial update was posted on 2007-11-20

MeSH Interventions

Cytarabine Etoposide Methylprednisolone Rituximab

MeSH Conditions

Aggression Lymphoma Lymphoma, Non-Hodgkin

Other Conditions


Stopping Reasons

The stopping rule was applied because of low response rates.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID